The COVID-19 pandemic isn’t just killing millions of people around the world, but has also laid out a treasure map that is now allowing a select group of international investors and companies to make a killing out of the killer virus that causes the yet incurable disease.
In the Philippines, vaccine suppliers stand to earn more than $1 billion in gross sales, the amount earmarked for vaccine purchase by the government, in 2021 alone.
Worldwide, estimates place the income pie that vaccine makers and suppliers will slice up and divide among themselves at $100 billion gross also in 2021. Profits are estimated to reach at least $26 billion.
…
Keep on reading: Vaccine profits: Making a killing from a killer virus